The FDA just issued a statement on the recent Lantus cancer issues that have been the subject of a media and medical frenzy lately.

The FDA says that it is aware of the recent published studies linking Lantus to cancer, but recommends that patients should not stop taking their insulin therapy without consulting a physician first.

The agency also says this:

FDA is currently reviewing many sources of safety data for Lantus, including these newly published observational studies, data from all completed controlled clinical trials, and information about ongoing controlled clinical trials, to better understand the risk, if any, for cancer associated with use of Lantus.

Discussions are also ongoing between FDA and the manufacturer of Lantus as to whether any additional studies evaluating the safety and efficacy of this drug will need to be performed.

FDA will communicate the results on its ongoing review to the public, as appropriate, as our review continues.

You can read all our previous Lantus coverage here, here, here and here.

Stay tuned…

Anonymous Tip? Comments? Contact us: hr AT iguanabio DOT com

Related Posts